The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program.
about
Costs associated with health care-associated infections in cardiac surgeryDoes preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting?Incidence and risk factors for and the effect of a program to reduce the incidence of surgical site infection after cardiac surgery.Center-level variation in infection rates after coronary artery bypass graftingEffects of preoperative aspirin on cardiocerebral and renal complications in non-emergent cardiac surgery patients: a sub-group and cohort studyChallenges of telerobotics in coronary bypass surgeryTelephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial.Accounting for the relationship between per diem cost and LOS when estimating hospitalization costsMedico-legal autopsy in postoperative hemodynamic collapse following coronary artery bypass surgery.Trends in aortic clamp use during coronary artery bypass surgery: effect of aortic clamping strategies on neurologic outcomesPerioperative dexmedetomidine improves mortality in patients undergoing coronary artery bypass surgery.Are there independent predisposing factors for postoperative infections following open heart surgery?Timing of depressive symptom onset and in-hospital complications among acute coronary syndrome inpatients.A cost study of postoperative cell salvage in the setting of elective primary hip and knee arthroplasty.Time-driven activity-based costing of multivessel coronary artery bypass grafting across national boundaries to identify improvement opportunities: study protocol.Quantifying the effect of complications on patient flow, costs and surgical throughputsInteraction of MIF Family Proteins in Myocardial Ischemia/Reperfusion Damage and Their Influence on Clinical Outcome of Cardiac Surgery PatientsSources of Variation in Hospital-Level Infection Rates After Coronary Artery Bypass Grafting: An Analysis of The Society of Thoracic Surgeons Adult Heart Surgery Database.Incidence, microbiological profile of nosocomial infections, and their antibiotic resistance patterns in a high volume Cardiac Surgical Intensive Care Unit.Postoperative differences between colonization and infection after pediatric cardiac surgery-a propensity matched analysis.Severe Obesity Is Associated With Increased Risk of Early Complications and Extended Length of Stay Following Coronary Artery Bypass Grafting Surgery.Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: Outcomes of a decision-analytic model.Partially anaortic clampless off-pump coronary artery bypass prevents neurologic injury compared to on-pump coronary surgery: a propensity score-matched study on 286 patientsHospital-Acquired Infections After Cardiac Surgery and Current Physician Practices: A Retrospective Cohort StudyEstablishing the case for minimally invasive, robotic-assisted CABG in the treatment of multivessel coronary artery disease.Predictors of total morbidity burden on days 3, 5 and 8 after cardiac surgery.ACE inhibitors in cardiac surgery: current studies and controversies.Impact of Medicare's payment policy on mediastinitis following coronary artery bypass graft surgery in US hospitals.Challenges facing totally endoscopic robotic coronary artery bypass grafting.Early and mid-term results of minimally invasive coronary artery bypass grafting.Plasma Monocyte Chemotactic Protein-1 Is Associated With Acute Kidney Injury and Death After Cardiac Operations.A prospective randomized multicenter trial shows improvement of sternum related complications in cardiac surgery with the Posthorax support vest.A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States.Determinants of Variation in Pneumonia Rates After Coronary Artery Bypass Grafting.Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.Outcomes and Costs of Cardiac Surgery in Adults with Congenital Heart Disease.Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study.Risks of Stroke After Coronary Artery Bypass Graft - Recent Insights and PerspectivesRelationship between endotoxin core, staphylococcal and varicella antibody levels and outcome following aortic valve replacement surgery: a prospective observational studyReduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery
P2860
Q30300984-1834AFC5-B60F-4F78-AE80-98D00EF3C973Q30369217-F2B37585-959E-45B1-8920-0E28A7D18370Q30410591-ACA3F5BC-5664-499F-BA2A-D63DBC1D3E82Q34033646-9A9F7FA4-6636-4913-BB5B-F11212D3A7B3Q34154557-5E4D20B2-7AA6-4577-9BDA-1B4D42E3B76FQ34222145-30FBFAFD-934A-44A2-963A-5D78815AB588Q34440434-CD8FCC5D-FCC7-4603-A234-CC1E44164027Q34496753-0A10B8E6-46B5-44BC-A41E-285773A740A0Q34551252-D489D7A0-42B0-40B3-BCBF-4BD85B67BD96Q34616117-291D4EDD-0622-4E36-9449-1977114A3785Q35483280-055B9A56-46E7-440D-8A30-2A09142EC351Q35570364-C4F53AF8-3DD0-4627-9D99-42707457181AQ35761345-1A4BAA50-E8EF-4703-874B-8D178B5CAA70Q35987765-8ADD819A-8163-4497-AF8B-491A6F28CB37Q35998907-4CDD87D9-C993-4507-8294-9A6D6DDD86D1Q36171403-57202A9D-9FB3-4F94-9289-B404F8F94C36Q36191684-DFA130EB-1C9C-448E-A743-5411851AAE5FQ36983009-4D8882FA-5E7A-4145-8A63-AE55E4925F3DQ36987943-002A5FCE-F8CA-4CC1-9BB5-92C99C095A53Q37000920-A539A4E0-BE5B-454E-B0B4-B9CC2CC55446Q37076158-29E08E88-22FC-49C5-A39A-8BAFA56F366DQ37090742-72721D2A-D95B-4A95-A2CE-FAAD3A16F870Q37230602-1456F0C8-19FA-4283-BE56-8F69960F4DF1Q37450704-12FE761C-BFB2-4CEC-8FE5-AC70E1AD8274Q37527385-392FA4DF-1D1C-4213-A942-D149321AEA60Q37640724-F0F84140-36DF-4B55-A1E9-4F9FC74D0B8FQ37800020-428101E8-C781-41A0-953E-EF7B5991329DQ38179951-A3E0DE2D-4357-4284-BAB6-84772E127E6EQ38221464-5B728464-DD9B-4EC1-A121-6E486AAA35B0Q39487625-98C68BC8-3C37-4BE5-9994-750B32ED9EA0Q40325080-790CD123-4198-4E4C-965A-63DC3CC411C9Q44291933-116DB64D-9AB7-4317-BA52-950302C40226Q45061743-2F7CF093-4AEA-4263-A575-6131C4E18781Q45073928-C4D9295E-03C4-46BA-9CF4-CFA07CB25856Q45301806-851DCC75-862F-4436-A792-0A484D113795Q47279240-9961B1CD-570E-4DB7-8830-B59DA20F54DDQ51392267-634321EA-61D5-4ED1-B03F-3BD99578560AQ56770670-87D3B974-AC7B-4877-8A44-38711830BEF2Q58714088-9B0AE6DF-4E50-4D17-87C5-FAD1A49B991BQ58797884-4E8333EE-8A8E-4B68-93BC-3A59A5E69721
P2860
The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The frequency and cost of comp ...... nited States Medicare program.
@en
The frequency and cost of comp ...... nited States Medicare program.
@nl
type
label
The frequency and cost of comp ...... nited States Medicare program.
@en
The frequency and cost of comp ...... nited States Medicare program.
@nl
prefLabel
The frequency and cost of comp ...... nited States Medicare program.
@en
The frequency and cost of comp ...... nited States Medicare program.
@nl
P2093
P1476
The frequency and cost of comp ...... United States Medicare program
@en
P2093
Aaron D Kugelmass
Ansley D Dee
April W Simon
David J Cohen
Phillip P Brown
P304
P356
10.1016/J.ATHORACSUR.2008.01.053
P407
P577
2008-06-01T00:00:00Z